ArticleClinical ophthalmology (Auckland, N.Z.)2021

Ripasudil Endgame: Role of Rho-Kinase Inhibitor as a Last-Ditch-Stand Towards Maximally Tolerated Medical Therapy to a Patient of Advanced Glaucoma.

Mayuresh Naik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.